Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC Keeping it real board for pro and con discussions -- Ignore unavailable to you. Want to Upgrade?

To: Puffer1 who wrote (12)	12/17/2014 11:16:46 PM
From: drkaz	Respond to of 326

:D Not much else to say here,....

To: Puffer1 who wrote (12)	12/20/2014 8:09:03 PM
From: Rawnoc	Respond to of 326

NanoViricides, Inc. Signs Agreement with a Major Pharma "It is the understanding of the Parties that, should the testing results be favorable, they will enter into good faith negotiations for a potential long-term, exclusive, worldwide licensing agreement for the development and commercialization of the drug." businesswire.com That was in 2009, and NNVC hasn't said a peep about it since. No wonder no other major pharma will touch this POS. I guess the testing results weren't too "favourable" eh?